Panagiota O.
- Country
- Greece
- Department
- 2nd Propaedeutic and Internal Medicine Clinic
Research Overview
Data & Insights
Has run more than one trial at 0 of 56 partner sites.
Specializations
Hematology and Myeloproliferative Disorders
The investigator’s work emphasizes malignant and proliferative diseases of the blood and bone marrow.
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Myelofibrosis
- Acute Lymphoblastic Leukemia
Active participation in clinical studies conducted at a university general hospital.
Solid Tumor Oncology
Focus is placed on a broad spectrum of solid cancers, ranging from thoracic to gynecologic sites.
- Non‑Small Cell Lung Cancer
- Breast Cancer
- Renal Cell Carcinoma
- Urothelial Carcinoma
- Ovarian Cancer
Clinical investigations address disease progression and therapeutic response.
Autoimmune and Inflammatory Diseases
Research targets chronic immune‑mediated conditions affecting multiple organ systems.
- Systemic Lupus Erythematosus
- Ulcerative Colitis
- Rheumatoid Arthritis
- Hidradenitis Suppurativa
- Juvenile Idiopathic Arthritis
Efforts include evaluating novel immunomodulatory agents.
Cardiovascular and Metabolic Disorders
Investigations address atherosclerotic disease, hypertension, and metabolic risk factors.
- Atherosclerotic Cardiovascular Disease
- Hypertension
- Obesity
- Elevated Lipoprotein(a)
- Type 2 Diabetes
Studies aim to reduce cardiovascular events through targeted therapies.
Neurology and Neurodegenerative Conditions
Clinical focus includes demyelinating diseases and cognitive impairment.
- Primary Progressive Multiple Sclerosis
- Relapsing Multiple Sclerosis
- Mild Cognitive Impairment
- Alzheimer’s Disease‑related Agitation
- Refractory Focal Onset Epilepsy
Research evaluates disease‑modifying strategies in neurologic populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.